MICHAEL R. DOUGHERTY - 03 Jan 2022 Form 4 Insider Report for IDERA PHARMACEUTICALS, INC.

Role
Director
Signature
/s/ Michael R. Dougherty
Issuer symbol
N/A
Transactions as of
03 Jan 2022
Net transactions value
+$21,867
Form type
4
Filing time
05 Jan 2022, 16:00:32 UTC
Previous filing
04 Oct 2021
Next filing
07 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IDRA Common Stock Award $21,867 +37,062 +24% $0.5900 191,875 03 Jan 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This stock was issued to the reporting person pursuant to his election, under the Issuer's director compensation program, to receive common stock in lieu of cash fees.